HHealth Read More Diabetes drugs linked to slower frailty progression in older adultsDecember 4, 2025 A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
HHealthcare Read More Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mgNovember 26, 2025 If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
HHealth Read More Searches for “Ozempic face” surge as people look for filler-based solutionsNovember 21, 2025 New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
HHealth Read More Study compares GLP-1 drug benefits and finds substantial variation in clinical effectsNovember 20, 2025 A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes…
MMedication Read More Weight-loss drugs: From a trickle to a floodNovember 17, 2025 It’s been varyingly called the “fat shot”, “skinny jab” or “magic pill” by politicians and celebrities who’ve put…
HHealth Read More ACTG Presents SLIM LIVER Findings at AASLD Liver MeetingNovember 10, 2025 LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and…
MMedication Read More Prices of Ozempic vs Mounjaro vs Wegovy: How much they cost in the US, UK, India and around the world |November 1, 2025 Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However,…
MMedication Read More Ozempic vs Mounjaro vs Wegovy: Prices in India vs US and what the research actually showsNovember 1, 2025 Ozempic, Mounjaro, Wegovy: Guide to Weight Loss Injections and Their Cost in India vs US Ozempic, Mounjaro and…
HHealth Read More Diabetes remission possible with GLP-1 drugs, Italian study confirmsOctober 30, 2025 Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
HHealth Read More Semaglutide protects the heart beyond weight loss, SELECT trial showsOctober 26, 2025 New findings from the landmark SELECT trial reveal that semaglutide’s cardiovascular benefits are only partly explained by reductions…
MMedication Read More Karan Johar’s Ozempic joke: What you ought to know about weight loss drugOctober 23, 2025 Ozempic 101: Is it behind Karan Johar’s weight loss? Fact sheet for health enthusiasts on benefits and risks…
HHealth Read More Resalis Therapeutics Reports Durable, Fat-Selective WeightOctober 7, 2025 Torino, Italy, October 7 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, presented new preclinical results on…